Durvalumab vs Ramipril
Durvalumab vs Ramipril: Overview
This comparison examines the pharmacological differences between Durvalumab and Ramipril.
Mechanism of Action
Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.
Ramipril: Prodrug converted to ramiprilat; ACE inhibitor.
Pharmacokinetics
Half-life: Durvalumab — 17 days; Ramipril — 13-17 hours.
Chemical Properties
Molecular Formula: Ramipril — C23H32N2O5.
Molecular Weight: Ramipril — 416.5120 g/mol.
Type: Durvalumab — Antibody; Ramipril — Small molecule.